Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines
Iris Glykofridis(Amsterdam University Medical Centers), Connie R. Jiménez(Amsterdam University Medical Centers)
Cited by 5
Related Papers
Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines
|Molecular & Cellular Proteomics|2020|46
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma
|Cell Reports|2023|26
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active phosphokinases
|bioRxiv (Cold Spring Harbor Laboratory)|2018|3